Sign inJoin waitlistJoin the waitlist

James Galvin

Program Director · University of Miami/Jackson Health System

Credentials: · · · · · · ·

History

University of Miami/Jackson Health System
Present
Division of Cognitive Neurology · University of Miami/Jackson Health System
Present
Comprehensive Center for Brain Health · University of Miami/Jackson Health System
Present

Neurology
1992–1996
Rutgers New Jersey Med Sch
1988–1992

Research

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
Review · Neurology · 2017 · 3,399 citations
The AD8: a brief informant interview to detect dementia
Neurology · 2005 · First of 9 authors · Corresponding · 934 citations
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
Review · Neurology · 2020 · 645 citations

John Morris
31 papers
Bradley Boeve
19 papers
Douglas Galasko
18 papers
James Leverenz
17 papers
John Trojanowski
15 papers
Melissa Armstrong
14 papers
Barbara Resnick
13 papers
Amie Rosenfeld
12 papers
JG
Jennifer Goldman
12 papers
Carol Lippa
11 papers
David Irwin
10 papers
Carol Manning
9 papers

Grants

Proof of Concept (Phase 0) Study of Clinical Trial Outcomes and Biomarkers in Early Stage Dementia with Lewy Bodies
National Institute on Aging · R01
Contact PI · $644K · University of Miami School of Medicine
2026–2031
Project LEARNS: Learning Alzheimer’s Results and Next Steps
National Institute on Aging · R01
Contact PI · $644.7K · University of Miami School of Medicine
2026–2031
FDA Approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in Cognitively Unimpaired Preclinical AD Participants.
National Institute on Aging · R01
PI · $10.2M · Institute for Molecular Medicine
2025–2030
IND Enabling CMC/Safety/Toxicology Studies, Submission of IND and Pilot Phase 1 Clinical Trial with PV-1950R Vaccine for Lewy Body Dementia (LBD)
National Institute on Aging · U01
PI · $5.4M · Institute for Molecular Medicine
2024–2029

Clinical trials

Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Principal investigator · Completed
Cognivue, Inc.
2022
The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
2020–2026
Pulsed Electromagnetic Field Treatment With Dementia Patients
Sub-investigator · Recruiting
Herrick Medical LLC
2025–2027